black box warning for glp 1 Medicare's GLP-1 subsidy risks creating lasting expectations US Food and Drug Administration
Description
GLP-1 receptor agonists have exploded in popularity, with prescriptions increasing by 364 percent between 2019 and 2024
Dont wait until youre extremely hungryby then, nausea from GLP-1 medications may make eating even harder
Notably, post-cessation weight or BMI gain was not associated with elevated risks of CVD, COPD, type 2 diabetes, or cancer []
Reuters (2023)
